Abstract
Automated powder dispensing systems enable supplying early clinical studies using drug-in-capsule approach, which is material sparing and requires a minimum amount of resources. However, the inability of accurately filling the capsule with a small amount, e.g., several micrograms, of drug limits the use of these systems for potent drugs. We demonstrate that formulated powder blends can be used to successfully fill capsules containing 5 μg to 5 mg of drug with adequate content uniformity. Effective formulation and process strategies that enable this approach are presented with examples.
Similar content being viewed by others
References
Orr NA, Sallam EA. Content uniformity of potent drugs in tablets. J Pharm Pharmacol. 1978;30:741–7.
DE Haan P, Zwinkels J, (1996) Antonius M. Process of making dosage units by wet granulation. W.O. Patent 9,609,056
Greaves FC, Swarbrick J, Suddith AW, Caldwell HC. (1999) Method for preparing low dose pharmaceutical products. U.S. Patent 5,976,570
Kvorning I, Koch K. (2002) Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis. W.O. Patent 0,247,692
Yalkowsky SH. (1984) Process for preparing solid unit dosage forms of ultra-low dose drugs. U.S. Patent 4,489,026
Katdare AV. (1990) Method for tablet preparation. U.S. Patent 4,898,736
Dahl TC, Burke G. Feasibility of manufacturing a solid dosage form using a liquid nonvolatile drug carrier: A physico-chemical characterization. Drug Dev Ind Pharm. 1990;16(12):1881–91.
Napper JA, Mortimer N, Manek SJ, Kumar R, O’Brien KT. (1997) Process for preparing solid dosage forms of very low-dose drugs. W.O. Patent 9,704,750
Wan LSC, Heng PWS, Muhuri G. Incorporation and distribution of a low dose drug in granules. Int J Pharm. 1992;88:159–63.
Herman V, Gerardi PJH. (1999) Making dosage units using low shear granulation. E.P. Patent 0,955,048
Funke A, Wagner T, Zurth C. (2006) Oral solid dosage forms containing a low dose of estradiol. W.O. Patent 2006/048261
Kristensen J, Hansen VW. Wet granulation in rotary processor and fluid bed: comparison of granule and tablet properties. AAPS PharmSciTech. 2006;7(1):E1–E10.
Thiel WJ, Nguyen LT, Stephenson PL. Fluidised bed granulation of an ordered powder mixture reduces the potential for ordered unit segregation. Powder Technol. 1983;34:75–80.
Thiel WJ, Nguyen LT, Sberna FJ. Content uniformity of microdose tablets (dosage 1 μg-10 mg) produced by fluid bed granulation of interactive mixtures. J Pharm Pharmacol. 1986;38:335–43.
Michoel A, Verlinden W, Rombaut P, Kinget R, Smet PD. Carrier granulation: a new procedure for the production of low-dosage forms. Pharm Technol. 1988;12(6):66–84.
Wu LS, Pang J, Chen JG, Hussain MA. Dry blending process scale-up for a very low dose drug candidate. AAPS PharmSciTech. 2000:1(3) Article TN2.
Roberto B, Angela A. (2005) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient. W.O. Patent 2005089717
Scott GD. (2002) Method for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency. W.O. Patent 02,087,546
Bryan L, Rungvejhavuttivittaya Y, Stewart PJ. Mixing and demixing of microdose quantities of sodium salicylate in a direct compression vehicle. Powder Technol. 1979;22:147–51.
Hersey JA. Ordered mixing: A new concept in powder mixing practice. Powder Technol. 1975;11:41–4.
Am Ende MT, Moses SK, Carella AJ, Gadkari RA, Graul TW, Otano AL. Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization. Pharm Dev tech. 2007;12:391–404.
Walker SE, Ganley JA, Bedford K, Eaves T. The filling of molten and thixotropic formulations into hard gelatin capsules. J Pharm Pharmacol. 1980;32:389–93.
Cole ET, Cade D, Benameur H. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev. 2008;60:747–56.
Meridica Inc. Xcelodose™ 600 micro-filling system User Manual. 2004:H:DDI-DD-0380-D.
Hariharan M, Ganorkar LD, Amidon GE, Cavallo A, Gatti P, Hageman MJ, et al. Reducing the time to develop and manufacture formulations for first oral dose in humans. Pharm Technol. 2003;27(10):68–84.
Rios M. The outsourcing advantages in formulation development. Pharm Technol. 2005;29(1):38–44.
Mouro D, Noack R, Musico B, King H, Shah U. Enhancement of Xcelodose capsule-filling capabilities using roller compaction. Pharm Technol. 2006;30:72–81.
Shotton E, Orr NA. Studies on mixing cohesive powders. J Pharm Pharmacol. 1971;23:260S.
Staniforth JN. Determination and handling of the total mixes in pharmaceutical systems. Powder Technol. 1982;33:147–59.
Johnson MCR. Particle size distribution of the active ingredient for solid dosage forms of low dosage. Pharm Acta Helv. 1972;47:546–59.
Yalkowsky SH, Bolton S. Particle size and content uniformity. Pharm Res. 1990;7:962–6.
Rohrs BR, Amidon GE, Meury RH, Secreast PJ, King HM, Skoug CJ. Particle size limits to meet USP content uniformity criteria for tablets and capsules. J Pharm Sci. 2006;95:1049–59.
Acknowledgment
Mike Kennedy, Dominick Daurio, Rick Chiu, Xuemei Wang, Lan Li, Shukun Wang, and Lu Xi are acknowledged for the partial data contributions to this research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bi, M., Sun, C.C., Alvarez, F. et al. The Manufacture of Low-Dose Oral Solid Dosage Form to Support Early Clinical Studies Using an Automated Micro-Filing System. AAPS PharmSciTech 12, 88–95 (2011). https://doi.org/10.1208/s12249-010-9549-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-010-9549-y